These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1410 related items for PubMed ID: 15018017

  • 1. Low-dose schema of isotretinoin in acne vulgaris.
    Mandekou-Lefaki I, Delli F, Teknetzis A, Euthimiadou R, Karakatsanis G.
    Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Oral isotretinoin in different dose regimens for acne vulgaris: a randomized comparative trial.
    Agarwal US, Besarwal RK, Bhola K.
    Indian J Dermatol Venereol Leprol; 2011; 77(6):688-94. PubMed ID: 22016276
    [Abstract] [Full Text] [Related]

  • 4. Low-dose isotretinoin in the treatment of acne vulgaris.
    Amichai B, Shemer A, Grunwald MH.
    J Am Acad Dermatol; 2006 Apr; 54(4):644-6. PubMed ID: 16546586
    [Abstract] [Full Text] [Related]

  • 5. Oral isotretinoin for acne, adjusting treatment according to patient's response.
    Ghaffarpour G, Mazloomi S, Soltani-Arabshahi R, Seyed KS.
    J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne.
    Kaymak Y, Ilter N.
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1256-60. PubMed ID: 17062042
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
    Boyraz N, Mustak PK.
    Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Recurrence in patients diagnosed with acne treated by isotretinoin and other methods].
    Bergler-Czop B, Brzezińska-Wcisło L.
    Wiad Lek; 2006 Oct; 59(3-4):152-7. PubMed ID: 16813256
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
    Azoulay L, Oraichi D, Bérard A.
    Br J Dermatol; 2007 Dec; 157(6):1240-8. PubMed ID: 17970803
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acute acne flare following isotretinoin administration: potential protective role of low starting dose.
    Borghi A, Mantovani L, Minghetti S, Virgili A, Bettoli V.
    Dermatology; 2009 Dec; 218(2):178-80. PubMed ID: 19060474
    [No Abstract] [Full Text] [Related]

  • 17. Psychological impact of isotretinoin treatment in patients with moderate and severe acne.
    Simić D, Situm M, Letica E, Penavić JZ, Zivković MV, Tomić T.
    Coll Antropol; 2009 Dec; 33 Suppl 2():15-9. PubMed ID: 20120397
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 71.